Benzinga | Oct 29, 2020 07:52AM EDT

Genocea Biosciences Q3 EPS $(0.26) Misses $(0.24) Estimate

Genocea Biosciences (NASDAQ:GNCA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 7.14 percent increase over losses of $(0.28) per share from the same period last year.